Privacy preferences
Inderes uses cookies to provide a better user experience and a personalised service. By consenting to the use of cookies, we can develop an even better service and will be able to provide content that is interesting to you.
  • Forum
  • Premium
  • Stock Markets
    • MarketsLive prices, indices, and market performance
    • Morning ReviewDaily market recap and key overnight highlights
    • Stock CalendarUpcoming earnings, listings, and corporate events
    • Dividends CalendarFuture and past dividends
  • Companies
    • CompaniesBrowse and filter the full list of listed companies
    • DiscoveryInspiration for your next investment
    • IPOsNew listings and upcoming public offerings
    • AGM InvitationsAnnual general meeting dates and shareholder info
  • Stock Research
    • ResearchExpert stock analysis and recommendations
    • ArticlesNews, insights, and market commentary
    • PortfolioInderes model portfolio
  • Learn about investing
    • Analysis SchoolLearn how to read and understand stock analysis
    • inderesTVVideo hub for stock research, analysis, and expert commentary
    • TranscriptsFull text records of earnings calls and investor meetings
    • Stock ComparisonCompare financials and performance across multiple stocks
    • Earnings SeasonCompare EPS estimates to reported results
    • Insider TransactionsTrack buying and selling activity by company insiders
    • Short SellingSee which listed companies have disclosed short interest
    • Virtual Analyst ChatAsk questions and get instant AI-powered investment insights
    • Compound Interest CalculatorSee how your savings grow with the power of compound interest.
Find us on social media
  • Inderes Forum
  • Youtube
  • Instagram
  • Facebook
  • X (Twitter)
Get in touch
  • info@inderes.se
  • +46 8 411 43 80
  • Vattugatan 17, 5tr
    111 52 Stockholm
Inderes
  • About us
  • Our team
  • Careers
  • Inderes as an investment
  • Services for listed companies
Our platform
  • FAQ
  • Q&A
  • Terms of service
  • Privacy policy
  • Disclaimer

Inderes’ Disclaimer can be found here. Detailed information about each share actively monitored by Inderes is available on the company-specific pages on Inderes’ website. © Inderes Oyj. All rights reserved.

Hamlet BioPharma

4.41 SEK-3.92 %19/11 15:21
Less than 1K followers

HAMLET B

Spotlight Stock Market

Biotechnology & Pharmaceuticals

Health Care

Overview
Financials & Estimates
Ownership
Dividend
Short Selling
Investor views
Compare
-3.92 %
-24.62 %
-34.38 %
-41.20 %
-25.25 %
-11.80 %
+147.75 %
-29.27 %
+99.32 %

Hamlet BioPharma operates in the pharmaceutical industry. The company conducts drug development based on a tumor-killing protein-lipid complex, formed from two natural and harmless molecules found in breast milk. The development aims to produce preparations that will primarily be used for the treatment and prevention of cancer diseases. Hamlet BioPharma was founded in 2015 and is headquartered in Lund.

Read more
Market cap
839.94M SEK
Turnover
254.27K SEK
Revenue
-
EBIT %
-
P/E
-
Dividend yield-%
-
EPS and dividend

EPS (adj.)

Dividend %

Financial calendar
All
Press releases
ShowingAll content types

Financial calendar
20/11
2026

General meeting '26

11/2
2027

Interim report Q2'27

20/5
2027

Interim report Q3'27

Press release2026-11-13 13:00

Hamlet BioPharma AB (publ): Hamlet BioPharma presented at Aktiespararna Life Science event on November 12th, 2026

Hamlet BioPharma
Regulatory press release2026-11-13 09:00

Q1 INTERIM REPORT JULY - SEPT 2026

Hamlet BioPharma
Press release2026-11-10 13:55

Hamlet BioPharma AB (publ): Blåscancerbehandling med Alpha1H uppmärksammas i internationell vetenskaplig publikation

Hamlet BioPharma

Join Inderes community

Don't miss out - create an account and get all the possible benefits

FREE account
Stock market's most popular morning newsletter
Analyst comments and recommendations
Stock comparison tool
Followings and notifications on followed companies
PREMIUM account
All company reports and deep analyses
Premium tools: model portfolio, screener, insider transactions
Premium columns: Guest column, expert insights
Inderes MCP - Inderes data directly into your AI tools
Create account
Press release2026-11-10 13:55

Hamlet BioPharma AB (publ): Bladder cancer treatment with Alpha1H Highlighted in International Scientific Publication

Hamlet BioPharma
Press release2026-11-09 11:10

Hamlet BioPharma AB (publ): Hamlet BioPharma presented at the BioStock Life Science Summit on November 5, 2026

Hamlet BioPharma
Regulatory press release2026-10-30 09:00

Hamlet BioPharma AB (publ): Hamlet BioPharma AB publicerar årsredovisning 2025/2026

Hamlet BioPharma
Press release2026-10-28 09:55

Hamlet BioPharma AB (publ): Invitation to Hamlet BioPharma's monthly digital meeting

Hamlet BioPharma
Regulatory press release2026-10-23 09:00

Hamlet BioPharma AB (publ): Kallelse till årsstämma i Hamlet BioPharma AB

Hamlet BioPharma
Press release2026-10-08 15:05

Hamlet BioPharma AB (publ): Alpha1H builds its scientific case as Phase III gets under way

Hamlet BioPharma
Press release2026-09-24 13:05

Hamlet BioPharma AB (publ): Hamlet Biopharma Is Profiled On `'The Bio Report'', One Of The Leading Biotech Podcasts In The World

Hamlet BioPharma
Press release2026-09-21 16:47

Nya BAMLET-resultat stärker satsningen inom metabol hälsa - nutrition första steg mot kommersialisering

Hamlet BioPharma
Press release2026-09-21 16:47

BAMLET treatment strengthens metabolic health - nutrition as a first step toward commercialization

Hamlet BioPharma
Press release2026-09-21 10:18

Hamlet BioPharma AB (publ): Hamlet BioPharma's monthly digital investors' meeting on September 23rd

Hamlet BioPharma
Regulatory press release2026-09-17 08:59

Hamlet BioPharma AB (publ): Successful patient enrolment in HAMLET BioPharma's Phase III bladder cancer trial

Hamlet BioPharma
Regulatory press release2026-08-28 09:00

Year-end Report (Q4) July 2025 - June 2026

Hamlet BioPharma
Press release2026-08-28 08:47

Investor Studios: Hamlet Biopharmas VD & ordförande presenterar rapporten live 12.00

Hamlet BioPharma
Press release2026-08-27 12:00

Hamlet BioPharma AB (publ): Hamlet BioPharma bjuder in till pressträff den 28 augusti

Hamlet BioPharma
Regulatory press release2026-08-05 16:37

Hamlet BioPharma AB (publ): Hamlet BioPharma tillförs preliminärt cirka 25,7 MSEK genom nyttjande av teckningsoptioner av serie TO5B

Hamlet BioPharma
Press release2026-07-28 13:00

Hamlet BioPharma AB (publ): Grant and impending grant of new patents in the US and Japan

Hamlet BioPharma
Press release2026-07-24 09:00

Hamlet BioPharma AB (publ): International traction for Hamlet BioPharma

Hamlet BioPharma